跳至主要内容
临床试验/NCT03299829
NCT03299829已完成不适用

A Retrospective Study to Assess the Clinical Efficacy and Safety of Trientine in Wilson's Disease Patients

Excelsior1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2018年1月10日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Excelsior
入组人数
48
试验地点
1
主要终点
The improvement in liver function

研究概览

简要总结

This is a retrospective study to assess the clinical efficacy and safety of trientine in Wilson's disease patients

详细描述

In this retrospective study, the investigators will collect and analyze data from reviewing medical history files of larger and long-term follow-up cohorts with Wilson's disease in Taiwan to assess the efficacy and safety of Trientine in Taiwanese Wilson's Disease patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
3 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Wilson's disease.
  • Male or female patients, aged 3 years to 75 years

排除标准

  • Patients with comorbidity which is not related to Wilson's disease.

结局指标

主要结局

The improvement in liver function

时间窗: Up to 1 year

To measure the AST (aspartate aminotransferase), ALT (alanine transaminase), GGT (gamma-glutamyl transpeptidase), Albumin, and Bilirubin level, and compare to the baseline

次要结局

  • The improvement in urine copper excretion(Up to 1 year)

研究者

发起方
Excelsior
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验